News & Perspective

Sep 05, 2002

Sep 05, 2002

Acambis reports successful phase I trial of cell-culture-grown smallpox vaccine

(CIDRAP News) Ð The smallpox vaccine being produced by Acambis plc for the US government as part of the nation's bioterrorism preparedness program worked well in a Phase I trial, Acambis officials announced this week.

The vaccine, called ACAM1000, generated a characteristic skin lesion or "take" in all those vaccinated, and there were no serious or unusual side effects, the company reported in a Sep 3 news release.

Oct 28, 2004

Oct 28, 2004

Progress on flu vaccine supply announced

(CIDRAP News) – About 5 million additional doses of injectable flu vaccine have been identified that will hopefully be added to the US supply, according to an announcement made today by Department of Health and Human Services (HHS) Secretary Tommy Thompson. In addition, 300,000 doses are being redirected to high-risk individuals from stores originally planned for military personnel and federal employees.

Dec 07, 2004

Dec 07, 2004

HHS buys 1.2 million flu vaccine doses from abroad

(CIDRAP News) – The federal government is buying 1.2 million doses of flu vaccine made in Germany to augment the strained US supply, the Department of Health and Human Services (HHS) announced today.

Mar 25, 2005

Mar 25, 2005

Two studies boost hopes for pandemic flu vaccines

(CIDRAP News) – Two new studies give reason to hope that vaccines prepared in advance could be of some help in combating an influenza pandemic.

Jun 27, 2005

Jun 27, 2005

Momentum builds for cell-culture flu vaccines

(CIDRAP News) – You've got to gather a lot of eggs to supply the world with influenza vaccine, but that might change before long.

Nov 08, 2005

Nov 08, 2005

US calls for expert panel to plan pandemic response

(CIDRAP News) – The United States proposed today that a small group of experts be appointed immediately to plan a fast response in case an influenza pandemic erupts, as an international conference on avian and pandemic flu continued in Geneva.

Mar 01, 2006

Mar 01, 2006

HHS orders drugs to treat 14 million in flu pandemic

(CIDRAP News) – US health officials announced today they have ordered more than 14 million treatment courses of two antiviral drugs to add to the 5.5 million courses already bought in preparation for a possible influenza pandemic.

May 04, 2006

May 04, 2006

US awards $1 billion for cell-based flu vaccines

(CIDRAP News) – In an effort to modernize vaccine production while preparing for an influenza pandemic, the US government today awarded five contracts totaling more than $1 billion to develop cell-based technologies for making flu vaccines.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Apr 27, 2007

Apr 27, 2007

Panel supports EU approval of cell-based flu vaccine

(CIDRAP News) – A committee that reviews medical product applications for the European Union (EU) yesterday recommended approval of a cell-based seasonal influenza vaccine made by Novartis, improving the company's chance of becoming the first to market a flu vaccine grown in cell culture instead of in eggs.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»